date,title,source
Oct-23-18,Naxitamab Receives Positive Opinion for Orphan Medicinal Product Designation Approval in the EU,GlobeNewswire
Nov-01-18,Bispecific GD2 Antibody In Vivo Data to be Presented at ASH,GlobeNewswire
Nov-13-18,Y-mAbs Announces Third Quarter 2018 Financial Results and Recent Corporate Developments,GlobeNewswire
Dec-10-18,Y-mAbs Therapeutics Announces FDA Clearance of IND for its Bispecific GD2 Antibody,GlobeNewswire
Dec-13-18,Y-mAbs Therapeutics To Present At 37th Annual J.P. Morgan Healthcare Conference,GlobeNewswire
Dec-20-18,"What Kind Of Investor Owns Most Of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB)?",Simply Wall St.
Feb-13-19,Y-mAbs Therapeutics to Present at PEGS Boston,GlobeNewswire
